The Nexperia dispute becomes the key variable for Wingtech Technology; Morgan Stanley downgrades to UW

Overview

This report is Morgan Stanley's rating update on Wingtech Technology Co Ltd (Wingtech Technology, 600745.SH). The core conclusion is that the Nexperia dispute has already had a significant negative impact on the company's day-to-day operations, wafer supply, and profitability, and the outcome remains highly uncertain in the near term; therefore, the stock is downgraded from EW to UW and the target price is cut sharply to Rmb15.

Core views

The report argues that Wingtech Technology's current problems mainly stem from the Nexperia dispute. Both 2025 and 1Q26 were loss-making periods, and Nexperia's overseas entities stopped supplying wafers to Nexperia China, disrupting the regular production of key products. If the dispute is resolved or supply chain rebuilding succeeds, the share price could have significant upside; but until the outcome becomes clear, investors are likely to remain cautious and the share price is more likely to face downside pressure.

Analysis framework

The analysis framework includes updating actual results, cutting 2026-2027 earnings estimates, introducing 2028 estimates, scenario valuation, and risk-reward analysis. The target price is based on a multi-stage residual income model, combined with a sum-of-the-parts approach to reflect differences across business segments; the report also presents bull, base, and bear scenarios.

Methodology notes

• Valuation methodsResidual Income Model (RIM) / SOTP

  Residual income model and sum-of-the-parts valuation

  The base-case target price of Rmb15 comes from a multi-stage residual income model, combined with a sum-of-the-parts approach to reflect differences across businesses such as semiconductors; the model assumes a 10% cost of equity and a 4.5% perpetual growth rate for semiconductors.

• Scenario analysisRisk Reward

  Bull, base, and bear scenarios

  The bull case of Rmb50 assumes the Nexperia dispute is resolved or the supply chain is successfully rebuilt; the base case of Rmb15 reflects continued negative impact; and the bear case of Rmb10 corresponds to further deterioration in the business.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Wingtech Technology Co Ltd (600745.SH)

  Covered company

  Strengths

  If the Nexperia dispute is resolved, semiconductor revenue and earnings could recover materially; the long-term semiconductor growth theme is still flagged as positive.

  Weaknesses

  Losses in 2025 and 1Q26, plus the wafer supply disruption at Nexperia, have affected production of key products, and the pace of recovery remains uncertain.

  Comparison

  Morgan Stanley's Rmb15 target price is significantly below the consensus mean of Rmb59, reflecting a more conservative Nexperia risk assumption.

  Risks

  No positive progress in the Nexperia dispute, failure to rebuild the supply chain, an earlier-than-expected semiconductor downturn, and obstacles to expansion execution.

• Nexperia

  Key subsidiary and central dispute variable

  Strengths

  If control is restored or the overseas asset issue is resolved, Wingtech Technology's operations could return to normal.

  Weaknesses

  Dutch government intervention and court investigations restrict Wingtech Technology's control over Nexperia's overseas entities, and those entities have suspended wafer supply to Nexperia China.

  Comparison

  Compared with other businesses, the Nexperia dispute has a more concentrated and binary impact on Wingtech Technology's current earnings and valuation.

  Risks

  The investigation continues, control cannot be restored, customer acceptance is insufficient, and the supply disruption persists.

Key data

• 2025 net profit-Rmb8.75bnThe company reported a net loss, mainly due to losing control of Nexperia and the divestiture of the ODM business.
• 1Q26 net profit-Rmb189.3mnA swing of more than Rmb450mn versus 1Q25.
• Target priceRmb15.00Lowered from Rmb50, implying about 0.7x 2026e P/B.
• Current priceRmb18.66The current price used in the risk-reward chart to calculate upside and downside versus the target price.
• Bull caseRmb50.00About +167.95% versus the current price, assuming the Nexperia dispute is resolved or the supply chain is successfully rebuilt.
• Bear caseRmb10.00About -46.41% versus the current price, corresponding to further business deterioration.
• Consensus mean target priceRmb59.00The chart shows that the consensus mean is significantly higher than Morgan Stanley's Rmb15 target price.

Impact & implications

The investment implication of the report is that short-term pricing for Wingtech Technology will depend heavily on developments in the Nexperia dispute. If the court investigation, control issue, and supply issue continue, the company's revenue, earnings, and valuation may remain under pressure; if the dispute is resolved or supply chain rebuilding is accepted by customers, there is significant rebound potential.

Risks

• The Nexperia dispute continues to disrupt business operations.
• Wingtech Technology fails to rebuild its supply chain or restore production of key products in the near term.
• The semiconductor industry downturn arrives earlier than expected.
• Semiconductor capacity expansion faces execution obstacles.
• Downstream auto demand is weaker than expected.

What to watch

• The latest progress in the Nexperia dispute and the Dutch court investigation.
• Whether Nexperia's overseas entities resume wafer supply to Nexperia China.
• The progress of Wingtech Technology's China supply chain rebuilding and end-customer acceptance.
• Whether 2026-2027 forecasts for revenue, EBITDA, net profit, and EPS are cut further.
• Changes in downstream auto demand and the semiconductor industry cycle.